Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 250 record(s)

Req # A-2023-025211

With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
July 2023

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023

Req # A-2023-025896

For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?

Organization: Patented Medicine Prices Review Board Canada

588 page(s)
July 2023

Req # A-2023-025600

For FY 2015-2022 (inclusive), how many Advance Certificate Rulings were issued by the board?

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
July 2023

Req # A-2023-00001

Please provide the total annual number of appeals heard by the Veterans Review and Appeal Board between FY 2018 and 2022, broken down according to virtual and in-person review hearings. Due to changes in business processes and how the information was captured for in-person and virtual hearings during the period of 2018-2022, it is not possible to accurately report on the breakdown. Veterans do not attend appeal hearings as the legislation does not permit oral testimony from Veterans at this level. Below is a table summarizing the number of VRAB Appeal Hearings held by Fiscal Year.

Organization: Veterans Review and Appeal Board

1 page(s)
July 2023

Req # A-2023-00002

For the fiscal years 2017-2022, please provide the total annual number of rehear decisions that were issued by the Veterans Review and Appeal Board following a Federal Court judicial review decision ordering the Board to rehear a matter.

Organization: Veterans Review and Appeal Board

1 page(s)
July 2023

Req # A-2023-00003

A-2023-00003 - For FY 2018-2022, please provide the total annual number and quantum (in dollars) of Compassionate Awards granted by the Veterans Review and Appeal Board pursuant to Section 34 of the Veterans Review and Appeal Board Act.

Organization: Veterans Review and Appeal Board

1 page(s)
July 2023

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

June 2023

Nothing to report this month

Organization: Veterans Review and Appeal Board

June 2023

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

May 2023
Date modified: